Literature DB >> 20868751

Astaxanthin-enriched-diet reduces blood pressure and improves cardiovascular parameters in spontaneously hypertensive rats.

José Monroy-Ruiz1, María-Ángeles Sevilla, Rosalía Carrón, María-José Montero.   

Abstract

The aim of this study was to investigate the effects of astaxanthin-enriched diet on blood pressure, cardiac hypertrophy, both vascular structure and function and superoxide ((*)O(2-)) production in spontaneously hypertensive rats (SHR). Twelve-week-old SHR were treated for 8 weeks with an astaxanthin-enriched diet (75 or 200mg/kg body weight per day). Systolic blood pressure was monitorized periodically during the study by the tail cuff method. At the end of the study animals were sacrificed and heart, kidneys and aorta were removed. Left ventricular weight/body weight ratio was used as left ventricular hypertrophy index (LVH). Vascular function and structure were studied in conductance (aortic rings) and resistance (renal vascular bed) arteries. Also (*)O(2-) production was evaluated by lucigenin-enhanced chemiluminescence. Systolic blood pressure was lower in astaxanthin-treated groups than the control group from the first week of treatment, and LVH was significantly reduced. Astaxanthin improved endothelial function on resistance arteries, but had no effect on aorta. These effects were accompanied by a decrease in oxidative stress and improvements in NO bioavailability. Taken together, these results show that diet supplemented with astaxanthin has beneficial effects on hypertension, by decreasing blood pressure values, improving cardiovascular remodeling and oxidative stress. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20868751     DOI: 10.1016/j.phrs.2010.09.003

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  18 in total

1.  Astaxanthin Ameliorates Blood Pressure in Salt-Induced Prehypertensive Rats Through ROS/MAPK/NF-κB Pathways in the Hypothalamic Paraventricular Nucleus.

Authors:  Hong-Li Gao; Xiao-Jing Yu; Yan Zhang; Chen-Long Wang; Yi-Ming Lei; Jia-Yue Yu; Dong-Miao Zong; Kai-Li Liu; Dong-Dong Zhang; Ying Li; Hua Tian; Nian-Ping Zhang; Yu-Ming Kang
Journal:  Cardiovasc Toxicol       Date:  2021-09-18       Impact factor: 3.231

Review 2.  The Putative Role of Astaxanthin in Neuroinflammation Modulation: Mechanisms and Therapeutic Potential.

Authors:  Shuai Wang; Xin Qi
Journal:  Front Pharmacol       Date:  2022-06-24       Impact factor: 5.988

Review 3.  Marine Microbial-Derived Resource Exploration: Uncovering the Hidden Potential of Marine Carotenoids.

Authors:  Ray Steven; Zalfa Humaira; Yosua Natanael; Fenny M Dwivany; Joko P Trinugroho; Ari Dwijayanti; Tati Kristianti; Trina Ekawati Tallei; Talha Bin Emran; Heewon Jeon; Fahad A Alhumaydhi; Ocky Karna Radjasa; Bonglee Kim
Journal:  Mar Drugs       Date:  2022-05-26       Impact factor: 6.085

Review 4.  Antioxidant-based therapies for angiotensin II-associated cardiovascular diseases.

Authors:  Erin G Rosenbaugh; Krupa K Savalia; Devika S Manickam; Matthew C Zimmerman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-04-03       Impact factor: 3.619

5.  Cytochrome P450 1B1 contributes to increased blood pressure and cardiovascular and renal dysfunction in spontaneously hypertensive rats.

Authors:  Brett L Jennings; David E Montanez; Michael E May; Anne M Estes; Xiao R Fang; Fariborz A Yaghini; Alie Kanu; Kafait U Malik
Journal:  Cardiovasc Drugs Ther       Date:  2014-04       Impact factor: 3.727

6.  Carotenoids: potential allies of cardiovascular health?

Authors:  Maria Alessandra Gammone; Graziano Riccioni; Nicolantonio D'Orazio
Journal:  Food Nutr Res       Date:  2015-02-06       Impact factor: 3.894

Review 7.  Astaxanthin as a Potential Neuroprotective Agent for Neurological Diseases.

Authors:  Haijian Wu; Huanjiang Niu; Anwen Shao; Cheng Wu; Brandon J Dixon; Jianmin Zhang; Shuxu Yang; Yirong Wang
Journal:  Mar Drugs       Date:  2015-09-11       Impact factor: 5.118

Review 8.  Astaxanthin: sources, extraction, stability, biological activities and its commercial applications--a review.

Authors:  Ranga Rao Ambati; Siew Moi Phang; Sarada Ravi; Ravishankar Gokare Aswathanarayana
Journal:  Mar Drugs       Date:  2014-01-07       Impact factor: 5.118

9.  A randomized, double-blind, placebo-controlled study of oral antioxidant supplement therapy in patients with dry eye syndrome.

Authors:  Jehn-Yu Huang; Po-Ting Yeh; Yu-Chih Hou
Journal:  Clin Ophthalmol       Date:  2016-05-09

10.  Annato extract and β-carotene modulate the production of reactive oxygen species/nitric oxide in neutrophils from diabetic rats.

Authors:  Joamyr Victor Rossoni-Júnior; Glaucy Rodrigues Araújo; Bruno da Cruz Pádua; Míriam Martins Chaves; Maria Lúcia Pedrosa; Marcelo Eustáquio Silva; Daniela Caldeira Costa
Journal:  J Clin Biochem Nutr       Date:  2011-12-07       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.